EMCURE PHARMA IPO NEWS
‘Only bullish corner’: Nithin Kamath flags ‘full-on party’ in IPOs amid broader market weakness
Indian equities remain under pressure, but recent mainboard IPOs are bucking the trend. Data cited by Zerodha CEO Nithin Kamath shows 67.2% of 125 IPOs listed between October 2025 and September 2026 traded above issue prices, with median returns of 24.7%.
HD Fire Protect IPO price band set at Rs 258-271; Rs 712 crore issue opens on October 13
HD Fire Protect has fixed the price band for its Rs 712.31 crore IPO at Rs 258-271 per share. The issue will open on October 13 and close on October 15, 2026. Entirely an offer for sale, the IPO will see promoters sell 2.63 crore shares, with the company receiving no proceeds from the issue.
Reliance Jio IPO clock ticking: Can you still buy RIL for shareholders quota amid October 21 launch buzz?
On October 21, Reliance Jio is preparing to launch its IPO, aiming to raise around $3.8 billion. Eligible shareholders of Reliance Industries will have the chance to participate through the shareholder quota, which is available for a limited period. This public offering represents a prime opportunity for investors keen on Jio Platforms.
Jio Platforms IPO: Rs 37,700 crore issue likely to open on Oct 21
Jio Platforms is preparing to launch what is anticipated to be India's largest initial public offering. Scheduled around Dussehra, the IPO is estimated at $4 billion and will likely occur later this month. The company aims to complete its IPO process, including listing, before October 30. Proceeds from the IPO will primarily be used for prepaying borrowings and general corporate purposes.
Jio IPO SWOT analysis: What the DRHP says about its growth story, moats and risks
Jio Platforms is gearing up for a landmark public offering to secure Rs 37,700 crore in funds, with subscriptions expected to commence on October 21. With an impressive customer base exceeding 524 million, Jio dominates India's wireless data landscape. The company is well-positioned to capitalize on opportunities like the shift from 2G to 4G and expanding enterprise connectivity.
- Go To Page 1
Vans Electroengineerings shares debut at 90% premium over IPO price on BSE SME; Black Opal Consultants sees flat debut. Check details
Three SME IPOs — Vans Electroengineerings, Papadmalji Agro Foods and Black Opal Consultants — made their D-Street debut on Wednesday. Vans Electroengineerings delivered a blockbuster 90% listing premium, while Black Opal Consultants and Papadmalji Agro Foods opened with modest gains. The three issues collectively raised around Rs 110 crore from investors.
ElevenLabs CEO on AI slowdown; Prosus dials up fintech bets
Happy Wednesday! ElevenLabs CEO Mati Staniszewski weighs in on the AI slowdown debate. This and more in today’s ETtech Morning Dispatch.
Market wrap: Trent, BSE, Coal India, Tech Mahindra top gainers and losers on Nifty and Sensex on Tuesday
Franklin India Small Cap Fund crossed Rs 14,000 crore in AUM, while a Rs 10,000 monthly SIP grew to nearly Rs 1.94 crore over 20 years. The fund has outperformed its benchmark over 15 years, highlighting long-term compounding and disciplined investing.
Swara Baby gets Sebi nod for Rs 1,000 crore IPO as hygiene products maker eyes expansion
Swara Baby Products has received approval from Sebi to proceed with its Rs 1,000 crore IPO. The IPO includes a fresh issue of equity shares and an offer for sale by promoters. Proceeds will be used for expanding a manufacturing facility and repaying borrowings among other corporate purposes. Founded in 2018, Swara Baby manufactures a range of disposable hygiene products for different consumer needs.
NSE shares wipe off Rs 41,000 crore after listing day pop as stock slips below IPO price. Why are analysts still bullish?
NSE shares have slipped below their IPO price after a brief listing-day rally, wiping out nearly Rs 41,000 crore from the exchange’s peak market value. Despite the decline, analysts remain bullish, citing NSE’s dominant market position, strong profitability, cash generation and India’s long-term capital-market growth potential.
Australia's Firmus to allocate half of up to $5.5 billion IPO to existing investors, sources say
Firmus, the Australian data centre operator, is gearing up for a noteworthy initial public offering worth $5.5 billion. In a strategic move, the company plans to distribute half of this capital to selected existing investors. Expected to commence trading on the Australian Securities Exchange on October 23, shares will be priced at A$11.
AMFI reshuffle: NSE may get largecap status, SBI Fund Management may become midcap in H1 CY27
Nuvama expects NSE to enter the largecap category and SBI Funds Management to become a midcap in AMFI’s H1 CY27 reshuffle. Bosch, Siemens Energy India and others may be upgraded, while several largecaps could move down. The revised classification will take effect from February 1, 2027, after H2 CY26 market-cap rankings.
Paramount Syntex subscribed 1.3 times on day 2 of bidding; QIB book hits 119 times
Paramount Syntex's Rs 82-crore IPO was subscribed 1.35 times on the second day of bidding on the BSE SME platform. The issue received bids for 82.39 lakh shares against 61.17 lakh shares on offer. The QIB portion was subscribed 119.29 times, while the retail and NII portions saw 10% and 2% subscription, respectively. The IPO closes on October 6.
Anthropic targets mega-IPO before Thanksgiving Holiday
Anthropic PBC is expected to start marketing its initial public offering around November 9. The company's trading debut could occur before Thanksgiving, which is on November 26. Although facing competition from OpenAI, investors remain optimistic about Anthropic's valuation. Despite significant losses, the firm aims to exceed SpaceX's record IPO size. The market for new listings has experienced delays, but Anthropic is pushing forward.
Carlsberg India unit, 3 other firms get Sebi nod to proceed with IPO plans
Sebi has provided observations for the IPOs of Carlsberg India, Matangi Rubber, Ujin Pharma, and TMC Transformer. Carlsberg's filing is under wraps, with specifics to be announced later. Matangi Rubber intends to issue 57.61 lakh new shares, complemented by an offer for sale. Ujin Pharma is looking to offer 1.18 crore shares, and TMC Transformer targets a substantial Rs 550 crore IPO, consisting solely of new issues.
Danish brewing giant Carlsberg’s India arm, 3 others get Sebi nod to float IPOs
In a significant move for India's market, Sebi has greenlit IPOs for Carlsberg's local entity, TMC Transformers, Ujin Pharma, and Matangi Rubber. TMC Transformers aims to raise Rs 550 crores via new equity to establish a manufacturing plant. Ujin Pharma's offering includes fresh shares and a sale from its promoters, while Carlsberg joins other global firms in this venture. Matangi Rubber has also successfully navigated the IPO approval process.
Carlsberg India IPO gets Sebi approval along with three other public offers. Check details
India’s IPO pipeline expands as Sebi clears papers for Carlsberg India, Matangi Rubber, Ujin Pharma and TMC Transformer. The approvals come amid strong primary-market activity, with over 50 companies filing draft IPO papers in September despite volatility in broader equity markets.
Inox Air Products files IPO papers; issue size not disclosed
Inox Air Products has unveiled a draft red herring prospectus as it seeks to raise substantial funds through an initial public offering. As a leading entity in India’s pure-play industrial gases sector, the firm, led by Pavan Kumar Jain, is set to sell existing shares specifically from its promoter group.
Vishal Nirmiti IPO Day 2: GMP at 16%, check subscription and key details. Should you apply?
Vishal Nirmiti IPO entered Day 2 of bidding with the Rs 178-crore issue subscribed 5% on Day 1, led by 6% subscription in the retail category. The IPO comprises a Rs 145-crore fresh issue and Rs 33-crore OFS, with the issue closing on October 5. premium listing. Shares are expected to list on NSE and BSE on October 8.
IPO Rush: Over 50 firms file DRHPs ahead of Sebi deadline
September 2025 marked a significant increase in Draft Red Herring Prospectuses submitted to Sebi with 55 submissions. Companies with a March 31 fiscal year end rushed to file before the September 30 deadline. Failing to meet this deadline could complicate their IPO plans, requiring updated audits and due diligence. The IPO market has surged since July, recovering from previous delays in activity.
Hospital stocks slip after SC query on steep cancer drug markups
In a landmark ruling, the Supreme Court of India highlighted troubling markups on cancer drugs enforced by hospitals, urging a probe into reports of patients being directed to specific pharmacies for their medications. Following this announcement, the BSE Hospitals Index faced a steep 5% drop, leading to notable losses for industry giants like Apollo Hospitals and Fortis Healthcare.
Coca-Cola mulls filing draft papers for $1 billion India IPO in December
Coca-Cola Co. plans to submit a draft prospectus by December for the anticipated IPO of Hindustan Coca-Cola Beverages Pvt. This offering, projected to garner about $1 billion, is expected to attract existing investors. With a valuation close to $10 billion, the deal highlights India's thriving investment landscape. The company has teamed up with various banks to streamline the process, riding the wave of recent IPO successes in the region.
ChrysCapital to take minority stake in Linux laboratories
Linux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involves both primary capital and a secondary purchase, marking Tata Capital Healthcare Fund II's full exit. The funding will help Linux deepen its presence in existing specialties and expand into new therapeutic areas.
5 SME IPOs to list today: Liqvd Digital, Unitec Fibres among most subscribed issues
On September 30, investors will witness the debut of five small and medium-sized enterprise IPOs, including Coreintegra Consulting and Pooja Logistics. Among these, Liqvd Digital stands out with an impressive subscription rate of 5.08 times. Coreintegra and Pooja also performed well, with subscriptions of 1.40 times and 3.11 times, respectively, while S.K. Offset and Unitec Fibres showed lower but notable interest.
8 SME IPOs to open today, seek to raise Rs 440 crore; check price bands, lot sizes and key dates
Eight SME IPOs — TNA Solutions, Omara Ventures India, Sollfege Smart Electronics, Eventions, Acme India Industries, Paramount Syntex, SJP Ultrasonics and Dove Soft — open for subscription today, September 30, collectively seeking to raise around Rs 440 crore. Seven will list on BSE SME, while Eventions will debut on NSE SME.
IPO pipeline swells to nearly Rs 4 lakh crore: Liquidity squeeze for secondary markets or valuation reset? Analysts weigh in
India's primary market is on the brink of a colossal IPO wave, with estimates nearing Rs 4 lakh crore. Analysts express concern that this influx might siphon off liquidity from the secondary market, which could adversely affect current stock values. While IPO activity undoubtedly impacts liquidity, experts emphasize that multiple factors shape market dynamics. Historical analysis indicates that secondary market valuations may eventually appeal more to investors.
Moneyview IPO Day 3: Issue subscribed over 98 times on strong QIB demand. GMP at 38%
The Moneyview IPO ended with 98.46 times subscription, led by strong demand from QIBs and NIIs. The Rs 1,091.68 crore issue received bids for 2,290 crore shares against 23.25 crore shares on offer. Its grey-market premium stood at 37.5%, implying an estimated listing price of Rs 46.75.
Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9
Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers all markets globally except for the United States and China. Lerodalcibep, a once-monthly PCSK9 inhibitor, will be marketed under the name Lyrokaul in Europe.
Load More
